DBV Technologies reports positive 3-year EPITOPE OLE data; 68.2% passed food challenge at month 36

DBV Technologies S.A.

68.2% of toddlers completed oral food challenge (~12-14 peanut kernels) without meeting stopping criteria at month 36, vs 30.7% at month 12.
83.5% reached eliciting dose ≥1000 mg after three years on Viaskin Peanut, up from 64.2% at month 12.
No treatment-related anaphylaxis or serious TEAEs occurred in year 3; local application-site reactions decreased vs earlier years.
New wear-time analysis: subjects with average daily wear time ≥20 hours (68.4% of active group) showed 75.7% responder rate vs 47.3% for <20 hours.
Data presented at Eastern Food Allergy & Comorbidity Conference; investor webcast on Jan 8, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.